Remove 2016 Remove Communication Remove Pharmaceutical Companies
article thumbnail

Time to change the channel? The future for customer engagement models

pharmaphorum

The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.

article thumbnail

NHS patient data upload delayed by two months, says UK

pharmaphorum

People can opt out of the scheme by filling in a form and taking it to their GP, but campaigners have complained that this was not communicated effectively and could place an onerous workload on GPs already battling to provide care amid the pandemic.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Where do most organizations start?

article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

“A lot of printed materials have been migrated to digital so that patients can opt-in to receive digital communications or HCPs can receive digital product or disease state information in the form of rep-triggered emails and microsites. Joanna Carlish. The idea is about really tapping into where the customer is in their journey.

article thumbnail

Sustainability: Corporate Ambition, Governance, & Accelerated Delivery

ISPE

A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. The risks are equally applicable to both privately owned and publicly traded companies.

article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Published 29 February 2016. Position paper.

article thumbnail

Campaigners challenge NHS England’s latest plan to share patient data

pharmaphorum

People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively. The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016.